Dr. med. Frederik L. Giesel, after graduating from medical school in Mainz and Heidelberg/GER Dr. Giesel went to the National Institutes of Health (NIH, Bethesda, USA) for his clerkship. The specialization (resident) began at the German Cancer Research Center (DKFZ) in Heidelberg with scientific visits to Texas University, USA and Sheffield University, UK, where he carries until today teaching activities in the field of imaging science. During his residency, he also completed a two year MBA-program at the Frankfurt School of Finance/ GER with several courses outside the country (London, Dubai, Tokyo, Boston). With the completion of specialist training (board certification) and habilitation he took a further specialization in the field of nuclear medicine at the University Hospital Heidelberg/ GER. Through his still close connection with the basic medical subjects (pre-clinical school) Dr. Giesel established the first to combine a series of seminars "Virtual Anatomy and Pathology" at the University of Heidelberg, the anatomy and pathology with diagnostic imaging. Today, Dr. Giesel is now Chairman of the Nuclear Medicine Department at the University Hospital Düsseldorf/ GER and also is appointed at the Osaka University/ Japan. Recently, he was visiting professor at the Stanford University, USA and Yonsei University, South Korea. Dr. Giesel has published over 130 scientific work and holds several patents in the field of imaging science and is board certified in radiology and nuclear medicine. Furthermore, he acquired over the last years over 2.5 Mio Euro research funds in the field of imaging sciences and image post processing. Today, Dr. Giesel leads the Phase I/II Multi-Center Study of a new PET-Tracer which has been recently introduced into the clinical environment for prostate cancer patients (Prostate Specific Membrane Antigen [PSMA]).
